Brazil’s President Lula da Silva and WHO Chief Tedros Adhanom Ghebreyesus Collaborate on Global Health Initiatives

Brazil’s President Luiz Inácio Lula da Silva and World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus have called on world leaders to finalize a legally binding agreement to prevent and respond to future pandemics, according to a joint statement released June 16, 2026. The agreement, negotiated under the WHO’s Intergovernmental Negotiating Body (INB), would establish global protocols for pandemic preparedness, including disease surveillance, vaccine equity, and cross-border coordination.

The push comes as global health officials warn that current pandemic response frameworks remain fragmented and underfunded. A WHO report released this month found that only 37% of countries have the capacity to detect and contain a novel pathogen within 24 hours—a critical gap exposed by COVID-19. The proposed agreement, expected to be finalized by late 2026, would require signatory nations to commit to mandatory data-sharing, equitable access to medical countermeasures, and rapid deployment of resources during outbreaks.

Why a Pandemic Treaty?

The WHO and Brazil’s advocacy follow years of stalled negotiations on a pandemic accord, originally proposed in 2021 after COVID-19 laid bare systemic failures in global health governance. The current draft, leaked in May 2026, includes provisions for a global stockpile of vaccines and treatments, but faces resistance from some nations over sovereignty concerns and funding mechanisms. Brazil, which has historically championed vaccine equity, has positioned itself as a mediator between high-income and developing countries in the talks.

“The COVID-19 pandemic cost the world over $16 trillion and took millions of lives,” Lula da Silva said in a statement. “We cannot afford to repeat these failures. A legally binding agreement is not optional—it is a matter of global survival.” Tedros echoed this urgency, stating that “without a treaty, the world remains vulnerable to the next pathogen, whether it emerges in a lab or a jungle.”

Key Stakes: What’s at Risk Without an Agreement?

Analysts warn that without a treaty, future outbreaks could trigger even more severe disruptions. A study published in The Lancet in June 2026 projected that a hypothetical pandemic with COVID-19-like severity but 20% higher transmissibility could cause $25 trillion in economic losses—double the current global GDP. The agreement’s failure to secure consensus could also undermine trust in the WHO, which has faced criticism for perceived inequities in vaccine distribution during COVID-19.

Brazil’s role in the negotiations is particularly significant. As the world’s largest tropical nation, it sits at the intersection of biodiversity hotspots—where zoonotic diseases like COVID-19 and Ebola often originate—and economic disparities that limit pandemic response capacity. “Brazil is not just a voice in these talks; it’s a lab for pandemic preparedness,” said Paulo Lotufo, a global health professor at the University of São Paulo. “Our experience with Zika, dengue, and now COVID-19 shows what’s at stake when the world fails to act.”

What Happens Next?

The INB is scheduled to hold its final round of negotiations in Geneva from July 15–20, 2026, with a vote on the treaty expected by September. Success hinges on resolving three major sticking points:

• Funding: Developing nations demand a $50 billion annual fund for pandemic preparedness, while wealthy countries propose a voluntary contribution model.
• Sovereignty: Some nations, including the U.S. and Russia, have resisted language that could be interpreted as overriding national health laws.
• Enforcement: The draft includes no penalties for non-compliance, raising questions about how the treaty would be upheld.

The WHO has framed the agreement as a “once-in-a-generation opportunity,” but diplomats acknowledge that political will remains fragile. “The window is closing,” said a senior UN official, who requested anonymity. “If leaders don’t act now, the next pandemic will find us even more unprepared.”

How Does This Compare to Past Efforts?

The proposed pandemic treaty builds on earlier but failed attempts to create global health governance frameworks. The 2005 International Health Regulations (IHR), for instance, lacked enforcement mechanisms and were widely criticized for their ineffectiveness during the Ebola and Zika outbreaks. The COVID-19 pandemic exposed further gaps, leading to the WHO’s 2021 call for a legally binding instrument—but negotiations have since stalled over competing national interests.

A key difference in the current draft is its emphasis on equitable access to medical tools. Unlike the IHR, which focused primarily on disease surveillance, the new agreement includes binding clauses for vaccine and treatment sharing. However, critics argue that without a clear enforcement mechanism, the treaty risks becoming another “aspirational document.”

Brazil’s push for the agreement also reflects its broader diplomatic strategy to position itself as a leader in global health equity. Since assuming office in January 2023, Lula has revived Brazil’s role in international forums, including the WHO and the Group of 20 (G20), where he has advocated for debt relief and technology transfers to developing nations. “This is not just about pandemics,” said Ana Maria Machado, Brazil’s ambassador to the UN. “It’s about rebuilding trust in global institutions.”

What’s the Likelihood of Success?

Prospects for a finalized treaty remain uncertain. While 194 countries have participated in the INB negotiations, deep divisions persist. The U.S., which has historically led pandemic funding, has signaled support for the framework but has not committed to the proposed $50 billion fund. Meanwhile, China has pushed for stronger language on “global solidarity,” a term some Western nations interpret as a veiled criticism of their vaccine policies.

In a June 15 interview with Folha de S.Paulo, Lula acknowledged the challenges but stressed that “the alternative is unacceptable.” The WHO’s Tedros has framed the treaty as a “moral imperative,” noting that “the cost of inaction is far greater than the cost of action.” As negotiations enter their final stretch, the focus will shift to whether leaders can overcome geopolitical tensions to deliver on a promise made six years ago.

For now, the world watches—and waits. The next pandemic could arrive before the ink is dry on the treaty.